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Tins study was undertaken to evaluate the role of
11-5 in eosinophil migration and in the main-
tenance of eosinophilia in a guinea-pig model of
visceral larva migrans syndrome. The results
show that the infection of animals with
Toxocara canis induced an early increase in
serum 11-5 levels that might be essential for eosi-
nophil differentiation and proliferation and for
the development of eosinophilia. When infected
guinea-pigs were treated with mAb anti-11-5
(TRFK-5) given at the same time or 1 or 3 days
after infection, there was a high percentage of
reduction of eosinophil counts 18 days after
infection. However, when the mAb was adminis-
tered during the peak of eosinophilia, there was
high inhibition in blood, no inhibition in
bronchoalveolar lavage fluid (BALF) or perito-
neum and an increase in eosinophil numbers in
bone marrow. Thus, a basic level of 11-5 may be
essential to drive eosinophils from bone marrow
to blood and tissues, and for the maintenance of
eosinophilia in infected animals. We may also
conclude that when eosinophils have already
migrated to the lungs, TRFK-5 has no power to
inhibit eosinophilia, which is also under control
of local lung cells producing 11-5. In this way,
only one later TRFK-5 treatment may not be suffi-
cient to modify the lung parenchyma micro-
environment, since T. canis antigens had already
stimulated some cell populations to produce 11-5.
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Introduction
Eosinophilia has been associated with parasitic
diseases, particularly when the parasites invade
the tissues or injure the mucosal surfaces. Tox-
ocara canis is an intestinal parasite of dogs, and
is the most common aetiologic agent of visceral
larva migrans syndrome (VLMS). In humans,
VLMS results from the ingestion of embryonated
eggs of T. canis, that eclode in the small intes-
fine. The infective larvae invade the mucosa,
move into the liver via the portal circulation, and
from there to the lungs.
2 Beaver et al.,
3 who
were the first to describe this syndrome, noted
the intense eosinophilia which reaches more
than 90% of total leucocyte counts. However,
there are few studies regarding the mechanisms
involved in the blood and tissue eosinophilia
obseeeed in VLMS.
Several investigators have suggested a direct
correlation between eosinophilia and interleukin-
5 (IL-5) in human helminth infections4’5 and in
67 experimental animal models. Inhibition of eosi-
nophilia has been demonstrated by anti-IL-5
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treatment in mice infected with Nipostrongylus
brasiliensis,
8 $chistosoma mansoni, Toxocara
canis7 and Heligmosomoidespolygyrus.
1 IL-5 has
also been shown to support the terminal differ-
entiation, proliferation of eosinophil pre-
cursors11’12 and eosinophil activation.13 Although
IL-5 does not demonstrate eosinophil chemotac-
tic activity in vivo
14 there is some evidence sug-
gesting that this cytokine may modulate a
selective eosinophil accumulation at the site of
inflammation. Moreover, Sehmi et a/.15 reported
that IL-5 has a selective priming effect on eosino-
phil migratory response to nonselective chemoat-
tractant mediators in vitro. Also, Moser et a/.16
have demonstrated that in order to acquire the
ability to transmigrate, eosinophils must be
primed with IL-5, IL-3 and GM-CSF. Thus, the
involvement of IL-5 in eosinophilia is not fully
understood.
In the present study we have used a guinea-pig
model of VLMS to investigate the involvement of
IL-5 in eosinophil migration and in the main-
tenance of eosinophilia in blood, bone marrow,
lung and peritoneal cavity.
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Materials and Methods were routinely processed, embedded in paraffin,
sectioned at 4-61.tm, and stained with Chro-
Animals: Outbred albino female guinea-pigs mothope 2R and haematoxylin, for examination
weighing 300-400g at the start of the experi- by light microscopy.
ments were obtained from the animal house of
the School of Medicine of Ribeiro Preto, Uni- Determination oflL-5 in serum: The IL-5 level in
versity of So Paulo, Brazil. the serum of guinea-pigs was measured using an
enzyme-linked immunosorbent assay (ELISA).
Infection ofanimals: T. canis eggs were obtained Briefly, ELISA plates (96-well Immunoplate Maxi-
by the methods of Olson and Schulz,
17 with Sorp, Nunc, Roskilde, Denmark) were coated
minor modifications. Briefly, gravid female with IL-5-specific monoclonal antibody (TRFK-5,
worms were recovered from dogs, and the eggs 5 lag/ml in phosphate buffered saline, pH 7.4,
were rescued from the uterus, washed and PBS, 100 l.tl/well). After 2 h of incubation at 37C,
allowed to develop to the infective stage in the wells were washed four times with PBS con-
shallow dishes containing 0.5% formalin at 37C. taining 0.1% Tween 20 (PBS-T). Then, 100 btl of
Under light ether anaesthesia, the animals were samples or recombinant murine IL-5 standards
infected with I ml saline containing 500 T. canis (0.15-200ng/ml) in PBS-T and 2% BSA (PBS-
eggs, by gastric intubation using a metal cannula. TBSA) were added to each well. After incubation
for l h at 37C, the wells were washed three
Blood cell counts: Guinea-pigs were anaesthetized times and 100 l.tl of biotinylated rat anti-murine
with sodium pentobarbitone (30mg/kg, i.v.) and IL-5 (biotinylated-TRFK-5, 1 lag/ml in PBS-TBSA)
blood samples were collected by cardiac punc- was added. After incubation for 1 h at 37C, the
ture with 10% EDTA. Total cell counts were wells were washed again three times and 100
carried out using diluting fluid in a Neubauer of peroxidase-labelled streptavidin (1/1000, Kir-
chamber. Differential countings were obtained kegaard & Perry Laboratories Inc., Maryland,
using Rosenfeld-stained cytocentrifuge prepara- USA) were added to each well. Following incuba-
tions, tion for l h at 37C and further washing, the
enzyme was developed using the TMB substrate
Bronchoalveolar lavage fluid. The guinea-pigs peroxidase for 5 min. The reaction was stopped
were killed by an overdose of sodium pento- by adding 501.tl of 2.0 N HCl, and the optical
barbitone and 5ml of phosphate-buffered saline densities were read at 490nm using an auto-
(PBS) containing 0.5% sodium citrate (PBS/SC), mated plate reader. The sensitivity of the assay
at room temperature, were instilled through a was 0.15 ng/ml and the upper limit 100ng/ml.
polyethylene cannula introduced into the trachea.
The cells present in the bronchoalveolar lavage Monoclonal antibodies: The rat monoclonal anti-
fluid (BALF) were recovered immediately. The body TRFK-5 was a generous gift from Dr P.
procedure was repeated once. The leucocyte Minoprio, Institut Pasteur, Paris. The neutralizing
counts in the BAI_ were determined as descri- antibody was purified by precipitation with
bed above, ammonium sulfate (45%) from ascites prepared
in CD1 nude mice (Charles River, St Aubin les
Peritoneal cells: The cells from the peritoneal Elbeuf, France) inoculated 1 week before the
cavities were harvested by injection of 10ml of injection of hybridoma cells, with I ml of pris-
PBS/SC into the peritoneum. Only 5-8 ml of the tane (Sigma). After precipitation and dialysis of
fluid was withdrawn for cell counts, as described the ascite fluid overnight against PBS, the dialy-
above, sate was further purified on a Protein G1 column
(HiTrapTM, Pharmacia Upsala, Sweden).
Bone marrow cells: Bone marrow cells were col-
lected by flushing the contents of the guinea-pig Eosinophil and cytokine depletion: Guinea-pigs
femur with 10 ml of PBS/SC. Total cell numbers were injected i.p. with TRFK-5 or with the irrele-
were determined as above. In the differential cell vant antibody (rat IgG against total anti-human
counts the cell populations were divided into IgG) once, 2mg/animal, at the time of infection
mature neutrophils, mature eosinophils and or at different intervals (1, 3, 12 or 17 days)
others (mainly precursors and mononuclear thereafter. The animals in this group were sacri-
cells), riced 18 days after infection.
Histopathological studies: Tissues were removed Recovery of larvae from liver: One lobule of
from guinea-pigs at various times post-infection each liver was used to determine the larval
and immediately fixed in 10% formalin. Tissues counts from infected guinea-pigs. Larval recovery
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was evaluated as described by Kayes and Oaks,
18
with minor modifications. Briefly, the tissue was
chopped and digested with pepsin-HC1 (pH 1.5-
1.8) for 2h at 37C. Larval counts for each
sample were performed after centrifugation and
examination of three 100-l.tl samples under the
light microscope.
Statistical analysis: Data are presented as the
mean _+ S.E.M. and were analysed statistically
using the Mann-Whitney test for unpaired data. A
p < 0.05 value was considered to be statistically
significant.
Results
Kinetics of eosinophil counts in blood bone
marrow, BALF and peritoneum: Guinea-pigs
infected with T. canis eggs showed a time-
dependent blood, bone-marrow, BAUV and peri-
toneal eosinophilia (Fig. 1). The results represent
the mean of nine animals obtained in three dif-
ferent experiments. The eosinophil number
16-
(AI
Blood
increased significantly from 0.55 +_ 0.37 x 105 at
the beginning of experiment to 6.0 +__ 1.03 x 105
at 6 days post-infection, peaked at day 18
(12.0 _+ 2.31 x 105), and decreased by day 24
(8.11 2.85 x 105) (Fig. 1A). A rise in the per-
centage of mature eosinophils in bone marrow"
was observed 12 days after infection (ranging
from 6 ___
2% to 14 ___
2%) and peaked at 18 days
(17 ___
2%) (Fig. 1B). As in blood, the number of
eosinophils in BALF increased significantly from
0.14 __. 0.06 x 105 to 1.37 _+ 0.35 x 105 at 6 days
after infection, reaching a peak at 18 days
(10.23 ___
2.62 x 105) with an increase in relative
number of as much as 90% in eosinophil counts
in relation to controls, and was still elevated at
day 24 (9.07___ 3.47 x 10s) (Fig. 1C). The
remaining cells in the BALF were alveolar macro-
phages, lymphocytes, mast cells and ciliated cells.
In contrast to blood and BALF, the number of
eosinophils in the peritoneal cavity increased sig-
nificantl only at day 12 post-infection (onset,
2.06 ___
1.04 x 105; day 6, 3.68 _+ 0.82 x 105; day
12, 5.77 +_ 1.12 x 10>; and increased progres-
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FIG. 1. Number of eosinophils in blood, BALF and peritoneal cavity, and percentage, of eosinophils in bone marrow of T. canisqnfected
guinea-pigs. Values are the mean -t-S.E.M. (n=8 to 9). Asterisks indicate a significant difference between infected and noninfected
animals (n 5 6). *p < 0.05 and **p < 0.01.
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sively until day 24, 12.44 4- 2.72 x 105) (Fig. 1D).
The percentage of eosinophils in some animals
reached 55% at the peak of infection. No
increase in the number of mononuclear cells was
seen in any compartment analysed.
Larval counts: The percentage of inoculated T.
canis larvae recovered by peptic digestion of the
liver of experimental animals 4 h and 1, 2, 3, 4, 9,
12 and 18 days after inoculation of 500 eggs per
animal is shown in Fig. 2. Most of the larvae
were recovered 2 to 4 days after infection and
10% recovery was also observed on day 18 in the
liver of the animals.
IL-5 level in serum of infected animals: IL-5 was
measured in the serum of infected and normal
guinea-pigs. Each time point in Fig. 3 represents
the mean of results from three to five infected
animals, and from six controls. Two peaks of IL-
5 were present in the serum of infected guinea-
pigs 1 day after infection (102 __+ 22 pg/ml), and
18 days later (59 ___
7 pg/ml). The level of IL-5 in
the controls was 31 4- 4 pg/ml.
Eosinophil numbers in infected animals treated
with TRFK-5: When guinea-pigs received an i.p.
injection of TRFK-5, the monoclonal antibody
against IL-5, at the time of egg administration or
1 day later, the number of eosinophils in blood,
BALF, peritoneal cavity and bone marrow was
60-
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FIG. 2. Percentage of T. canis larvae recovered from liver of
guinea-pigs studied at various times post-infection. Data obtained
from five animals.
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FIG. 3. IL-5 concentration in serum of T. caniinfected guinea-
pigs (n 3-5). Basal IL-5 concentrations were of 31 ___
4 pg/ml
(n= 12).
drastically reduced, even when determined 18
days after infection (Table 1). No inhibition of
eosinophil counts was observed when the
animals were inoculated with the irrelevant anti-
body at the time of infection (Table 1).
Fig. 4 shows the comparative results of eosino-
philia obtained when the antibody was given 3
days or 17 days after egg inoculation. The anti-
body given at 3 days after infection induced a
high percentage of inhibition in eosinophil
counts in all the compartments analysed 18 days
after infection (Fig. 4A). However, when TRFK-5
was administered to the infected animals on day
17 post-infection (thus 1 day before sacrifice), a
significant inhibition in number and percentage
of eosinophils was observed only in the blood
(p=0.030) (Fig. 4B). A small non-significant
decrease was seen in BALF (p 0.790) and peri-
toneum (p= 0.222). Moreover, the number of
mature eosinophils in bone marrow increased by
140% (p 0.038).
As demonstrated in Fig. 4B, the behaviour of
eosinotShilia in BALF was completely different
from that observed in blood. Thus, to better
understand the eosinophilia in the lungs of infec-
ted animals, we monitored eosinophil numbers
in BALF after administration of TRFK-5 at the
same time, or 1, 3, 12 or 17 days after infection.
The animals were sacrificed 18 days after infec-
tion. In another group, TRFK-5 was administered
18 days post-infection and the animals were
sacrificed 6 days later. When the mAb was admi-
nistered at the same time or 1 or 3 days post-
infection there was a significant inhibition in the
number of eosinophils (Fig. 5). These data show
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Table 1. Eosinophils in T. caniinfected guinea-pigs treated or untreated with TRFK-5
Compart- Time of Days of treatment with TRFK-5 Irrelevant Ab
ment sacrifice after egg administration at the time
(days) of infection
Non- 0 3 12 17 18
treated (n 6) (n=4) (n=4) (n 5) (n 5) (n=4)
Blood 18 12.18 ___
5.28 0.14 -t- 0.14" 0.26 0.26* 0.17 _-t- 0.17" 0.15 0.15" 2.59 _
0.80* 13.32 ___
4.54
24 10.08 -t- 2.85 O. 15 _
0.15*
BALF 18 16.50 4.42 0.36 _
0.10" 0.79 _
0.24* 1.22 -t- 0.50* 7.07 -t- 2.39 15.24 ___
4.36 29.31 _+ 15.90
24 6.57 +__ 1.68 10.33 _+ 4.10
Peritoneal 18 12.31 -I- 2.35 1.47 -t- 0.76* 0.48 _+ 0.35* 0.46 _
0.27* 2.89 _
0.94* 10.42 _
2.21
cavity 24 12.44 _
2.33 3.79 ___
1.58"
Bone 18 9 -+ 3 _
1" 1.25 -I- 0.25* 2.6 + 1.3" 5 15 -t- 2
marrow 24 6 _
2 _
0.7*
16.09 ___
4.00
9_+1
In blood BALF and peritoneal cavity the values represent mean -t-_ S.E.M. x 10 ml-1 and in bone marrow mean -t-_ S.E.M. of the percentage of mature
eosinophils. *p < 0.05.
that the inhibition of the first peak of IL-5 which
appeared at 1 to 3 days after infection as shown
in Fig. 3, is also very important for the establish-
ment of eosinophilia in the lungs. However,
when the mAb was administered 12, 17 or 18
days after infection there was no significant inhi-
bition in the numbers of eosinophils in BALF
(Fig. 5), showing that once established, the eosi-
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FIG. 4. Number of eosinophils in blood, BALF and peritoneum and percentage of eosinophils in bone marrow of T. caniinfected
guinea-pigs submitted or not to treatment with TRFK-5. (A) 2 mg/animal at 3 days post-infection; (B) 2 mg/animal 17 days post-infec-
tion. The treated and control animals were sacrificed 18 days after infection. Asterisks indicate a significant difference from infected
controls (n=5-6) and from animals treated with TRFK-5 (n=4- 5). *p < 0.05 and **p < 0.01.
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heart; data not shown) and muscle, as reported
by other investigators,
8 were infiltrated.
The factors responsible for in vivo eosinophil
accumulation at inflammatory sites have been
poorly defined, although T lymphocytes and mast
cells appear to be involved in eosinophilia.9’2
IL-5, a T cell-derived factor that regulates B cell
functions, is an eosinophil differentiation factor
11
as well as a stimulating and survival-prolonging
factor specific for eosinophils in vitro.
2 Also,
several investigators have demonstrated that sTs-
temic eosinophilia in mice infected with parasites
is mediated by IL-5 produced in response to the
infection.2’22 In the present study, the i.p.
administration of the TRFK-5 antibody markedly
inhibited the widespread eosinophilia observed
FIG. 5. Number of eosinophils in BALF of T. caniinfected
guinea-pigs submitted or not to treatment with TRFK-5. (A) in T. canis-infected guinea-pigs, indicating that IL-
animals were sacrificed 18 days post-infection and (B) 24 days 5 participated in a guinea-pig model of VLMS
after infection. Asterisks indicate a significant difference from eosinophJlia.
infected control and from animals treated with TRFK-5 Most of the T. canis larvae which penetrated (p< 0.01).
the intestinal wall had migrated into the liver
within 72h after inoculation as demonstrated
nophilia persists in lungs, probably by the secre- here and elsewhere.2 It is apparently during this
tion of IL-5 from cells localized in the lung interval that the worm provides the signals to
microenvironment, cytokine-producing cells, which in turn trigger
increased serum levels of specific cytokine as
Histopathological analysis: The treatment of T. demonstrated here for IL-5, 24 to 72 h after infec-
canis-infected animals with irrelevant antibody tion. The signals may be provided directly by the
showed a widespread eosinophilic infiltration as invading parasite or by cells in response to the
in untreated animals (Fig. 6A,B). However, the parasite. The cytokine pattern that develops at
treatment of animals with TRFK-5 at the same this early stage, probably induced by a T-cell
time of infection, or 1 day or 3 days later ted to independent pathway, may also influence the
a complete inhibition of eosinophil infiltration in pattern of T cell differentiation into a Th2 type,
the lung parenchyma (Fig. 6C). By contrast, the which may be responsible for the second peak
mononuclear cell infiltration in the lungs was of IL-5 observed in our experimental model
not modified. When the infected guinea-pigs (Fig. 3), although a second cycle of larval inva-
received TRFK-5 1 day before sacrifice (or 17 sion (Fig. 2) with a rapid peak of IL-5 liberation
days post-infection), eosinophil infiltration in the cannot be ruled out.
lung parenchyma was also inhibited (Fig. 6D) Thus, our results suggest that the eosinophilia
but not to the same extent as observed in the against helminth larvae may be initiated by the
group receiving TRFK-5 given at the time of release of IL-5 when the parasites migrate from
infection or 3 days later. Thus, the histological the intestine to the liver by stimulation of specific
determination of eosinophil infiltration in these cell populations. Then, an early release of IL-5
lungs corroborates a reduction but not a size- quickly induces eosinophil recruitment, probably
able inhibition of eosinophil numbers as first from the stored mature eosinophil pool
observed in the BALF of the same infected from vascular endothelium or by the mobiliza-
animals, tion of eosinophils from extravascular sites to the
blood. This fact could explain why we found
Discussion increased eosinophils first in blood and later in
other compartments. The early IL-5 release may
The results of the present study show that in also serve as a signal for eosinophil differentia-
our experimental model widespread eosinophilia tion and maturation in bone marrow. The time
follows the infection of guinea-pigs with second inteeeal observed between the first peak of IL-5
stage eggs from T. canis, as also noted in release and the increase of eosinophils in blood
humans and in other experimental animals.7’7 T. coincides with that reported to be necessary for
canis is a potent stimulus for systemic eosino- eosinophil differentiation and maturation in
12 philia, since blood, BALF, peritoneum and all vitro. Increased eosinophil production and lib-
tissues examined (kidney, eyes, spleen, thymus, eration into blood and other tissues occurs
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FIG. 6. (A) photomicrographs of lung parenchyma from guinea-pigs infected for 18 days with T. cani,, (B) infected animals which were
treated with irrelevant antibody at the time of infection; (C) infected animals which were treated with the mAb TRFK-5 at 3 days after
infection; (D) mAb administration 17 days after infection. The animals were sacrificed 18 days after infection. Note the intense eosino-
phil infiltration into the lung in A and B, the inhibition of eosinophils in C and the reduction of eosinophils in D.
thereafter. Thus, early and later IL-5 release pro-
vides a necessary level of this cytokine, which is
involved in the maintenance of eosinophilia. We
may assume that the inhibition of the first peak
of IL-5 release by TRFK-5 does not permit the
subsequent T cell stimulation and differentiation.
This may explain the long-lasting effect of TRFK-
5 treatment observed here and also reported by
others.
8 In agreement with our results, there is
an important observation of Svetic et al.
24
showing that a specific and highly reproducible
IL-5 gene expression pattern is detectable in
Peyer’s patches by 6 to 12h after Heligmoso-
moides polygyrus infection. The early increase in
IL-5 gene expression after infection was probably
T cell-independent, inasmuch as it was obseeeed
in Peyer’s patches of congenitally athymic mice
and of conventional mice treated with anti-CD4
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and anti-CD8 mAb. Moreover, Kusama eta/.25
have observed two peaks of eosinophilia in
normal and athymic mice, and suggested that IL-5
observed in the first peak was produced by cells
other than CD4 T cells, since anti-CD4 and
anti-CD3 mAb reduced only the second peak of
eosinophilia in normal mice and slightly reduced
the first peak of eosinophilia in both normal and
nu/nu mice. The local lung cells producing IL-5
may also help us to explain the reason why 12,
17 or 18 days post-infection TRFK-5 treatment
only partially inhibits, or does not inhibit eosino-
phil infiltration into the lungs, as demonstrated
in Figs 5 and 6. We may suggest that when
eosinophils have already migrated to the lungs,
TRFK-5 has no power to inhibit eosinophilia,
which is also under control of local lung cells
producing IL-5. In this way, only one later TRFK-IL-5 drives eosinophils in guinea-pig
5 treatment may not be sufficient to modify the
lung parenchyma microenvironment, since T.
canis antigens have already stimulated some cell
populations to produce IL-5, as demonstrated by
Kusama et aL25These results suggest that eosi-
nophilia in lungs is under the control of differ-
ent factors when compared to that observed in
blood and the peritoneal cavity.
One of the most important results obtained
here was the inhibition of circulating eosinophil
numbers by the different mAb treatments, even
when the antibody was given at the peak of
blood eosinophilia, which was accompanied by
an increase of mature eosinophils in bone
marrow. This suggests that IL-5, apart from being
required for the terminal differentiation of
eosinophils in bone marrow,
26 is also likely to
drive eosinophils from the bone marrow to the
blood and then to the tissues, probably by up-
regulating VLA-4 expression in eosinophils.
Moser et aL have demonstrated that in order to
acquire the ability to transmigrate, eosinophils
must be primed with cytokines such as IL-5, IL-3
or GM-CSF for expression of adhesion mole-
cules such as VI-4. Recently, Pretolani et al.27
have indeed shown that an anti-VLA-4 antibody
suppresses eosinophil recruitment to lung in the
guinea-pig and, as a consequence, inhibits the
accompanying bronchopulmonary hyperrespon-
siveness.
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